PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma
Journal: Nature Communications
Published: 2020-05-01
DOI: 10.1038/s41467-020-15959-6
Affiliations: 10
Go to articleJournal: Nature Communications
Published: 2020-05-01
DOI: 10.1038/s41467-020-15959-6
Affiliations: 10
Go to article